Organism name | Helianthus annuus |
---|---|
Genus | Helianthus |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Helianthus annuus |
---|---|
Linked NCBI taxonomy ID | 4232 |
Linked level | species |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006651
![]() |
Cyanidin 3-xyloside
|
No. 2 | No. 15 |
![]() |
||||
C00002374
![]() |
Chrysanthemin
/ Cyanidin 3-O-glucoside |
CHEMBL257839
CHEMBL1197952 |
C114438
|
1 / 0 / 1 | No. 2 | No. 15 |
![]() |
|
C00001104
![]() |
Tambulin
|
CHEMBL478811
|
No. 3 | No. 15 |
![]() |
|||
C00039358
![]() |
Helianthoside 1
|
CHEMBL427433
|
No. 4 | No. 51 |
![]() |
|||
C00039363
![]() |
Helianthoside B
|
CHEMBL227304
|
No. 4 | No. 51 |
![]() |
|||
C00003530
![]() |
Helianthoside A
|
No. 4 | No. 51 |
![]() |
||||
C00039359
![]() |
Helianthoside 2
|
CHEMBL388346
|
No. 4 | No. 51 |
![]() |
|||
C00039362
![]() |
Helianthoside 5
|
CHEMBL227303
|
No. 4 | No. 51 |
![]() |
|||
C00039361
![]() |
Helianthoside 4
|
CHEMBL437173
|
No. 4 | No. 51 |
![]() |
|||
C00039360
![]() |
Helianthoside 3
|
CHEMBL227302
|
No. 4 | No. 51 |
![]() |
|||
C00000068
![]() |
GA68
/ Gibberellin A68 |
No. 40 | No. 41 |
![]() |
||||
C00000072
![]() |
GA72
/ Gibberellin A72 |
No. 40 | No. 41 |
![]() |
||||
C00000075
![]() |
GA75
/ Gibberellin A75 |
No. 40 | No. 41 |
![]() |
||||
C00000076
![]() |
GA76
/ Gibberellin A76 |
No. 40 | No. 41 |
![]() |
||||
C00000067
![]() |
GA67
/ Gibberellin A67 |
No. 40 | No. 41 |
![]() |
||||
C00000064
![]() |
GA64
/ Gibberellin A64 |
No. 40 | No. 41 |
![]() |
||||
C00000045
![]() |
GA45
/ Gibberellin A45 |
No. 40 | No. 41 |
![]() |
||||
C00000044
![]() |
GA44
/ Gibberellin A44 |
No. 40 | No. 41 |
![]() |
||||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00000004
![]() |
GA4
/ Gibberellin A4 |
No. 40 | No. 41 |
![]() |
||||
C00000001
![]() |
GA1
/ Gibberellin A1 |
C422660
|
No. 40 | No. 41 |
![]() |
|||
C00000574
![]() |
GA101
/ Gibberellin A101 |
No. 40 | No. 41 |
![]() |
||||
C00000176
![]() |
Brassinolide
|
CHEMBL563853
CHEMBL1801925 CHEMBL1967970 |
C023623
|
16 / 2 | No. 68 | No. 11 |
![]() |
|
C00000181
![]() |
Castasterone
|
C083545
|
No. 68 | No. 11 |
![]() |
|||
C00000189
![]() |
Brassinone
/ Norcastasterone / 28-Norcastasterone |
No. 68 | No. 11 |
![]() |
||||
C00014421
![]() |
Heliannone A
/ 2',4-Dihydroxy-3',4'-dimethoxychalcone |
No. 79 |
![]() |
|||||
C00003338
![]() |
Niveusin C
|
No. 94 | No. 38 |
![]() |
||||
C00003785
![]() |
Rubixanthin
|
No. 131 | No. 59 |
![]() |
||||
C00000066
![]() |
GA66
/ Gibberellin A66 |
No. 187 | No. 41 |
![]() |
||||
C00000065
![]() |
GA65
/ Gibberellin A65 |
No. 187 | No. 41 |
![]() |
||||
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00000324
![]() |
GA100
/ Gibberellin A100 |
No. 187 | No. 41 |
![]() |
||||
C00007865
![]() |
GA102
/ Gibberellin A102 |
No. 187 | No. 41 |
![]() |
||||
C00022912
![]() |
Deepoxyneoxanthin
/ (3R,3'R)-6,7-Didehydro-5,6-dihydro-3,3',5-trihydroxy-beta,beta-carotene |
No. 664 | No. 59 |
![]() |
||||
C00000218
![]() |
Jasmonic acid
/ trans-Jasmonic acid / 3-Oxo-2-(2Z-pentenyl)cyclotentylacetic acid |
CHEMBL445499
CHEMBL449572 |
C011006
|
4 / 1 / 0 | No. 707 | No. 70 |
![]() |
|
C00000109
![]() |
Indole-3-acetaldehyde
|
C001655
|
No. 710 | No. 4 |
![]() |
|||
C00000114
![]() |
Tryptophol
/ Indole-3-ethanol |
CHEMBL226545
|
C005949
|
2 / 4 / 2 | No. 710 | No. 4 |
![]() |
|
C00049723
![]() |
Heliannuol K
/ (+)-Heliannuol K |
No. 1453 |
![]() |
|||||
C00037248
![]() |
Helianyl octanoate
|
No. 2571 |
![]() |
|||||
C00000578
![]() |
Ayapin
|
CHEMBL595798
|
No. 2617 |
![]() |
||||
C00000091
![]() |
trans-Zeatin
|
CHEMBL525239
|
D015026
|
2 / 3 / 2 | 0 / 1 | No. 2879 |
![]() |
|
C00014651
![]() |
5-Hydroxy-4,6,4'-trimethoxyaurone
|
No. 3237 |
![]() |
|||||
C00001183
![]() |
Fumaric acid
|
CHEMBL503160
CHEMBL539648 |
C032005
|
17 / 14 / 46 | 0 / 1 | No. 3766 |
![]() |
|
C00001151
![]() |
Sucrose
/ (+)-Sucrose |
CHEMBL253582
CHEMBL1976550 |
D013395
|
1 / 0 / 0 | 4 / 10 | No. 3949 |
![]() |
|
C00007452
![]() |
Sucrose 6-phosphate
|
C535046
|
No. 3949 |
![]() |
||||
C00000318
![]() |
Caprolactam
|
CHEMBL276218
|
D002209
|
No. 5191 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000091 C00001183 | 3 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00000114 | 4 / 2 |
Q16798 | NADP-dependent malic enzyme, mitochondrial | Enzyme | C00001183 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001183 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001183 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00002374 | 0 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001183 | 7 / 37 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001183 | 1 / 2 |
P02768 | Serum albumin | Secreted protein | C00001151 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001183 | 1 / 1 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000218 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00001183 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001183 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000218 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001183 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000114 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001183 | 1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001183 | 0 / 0 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000218 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001183 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000218 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001183 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001183 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001183 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000091 | 0 / 0 |
Q9C0B1 | Alpha-ketoglutarate-dependent dioxygenase FTO | Unclassified protein | C00001183 | 1 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000176
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000176
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000176
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000176
|
891 | CCNB1, CCNB | cyclin B1 |
C00000176
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000176
|
898 | CCNE1, CCNE | cyclin E1 |
C00000176
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000176
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000176
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000176
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000176
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000176
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000176
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000176
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000176
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000176
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001151
|
55630 | SLC39A4, AEZ, AWMS2, ZIP4 | solute carrier family 39 (zinc transporter), member 4 |
C00001151
|
80834 | TAS1R2, GPR71, T1R2, TR2 | taste receptor, type 1, member 2 |
C00001151
|
83756 | TAS1R3, T1R3 | taste receptor, type 1, member 3 |
C00001151
|
OMIM | preferred title | UniProt |
---|---|---|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#612219 | Ewing sarcoma; es |
P11308
|
#612938 | Growth retardation, developmental delay, coarse facies, and early death; gdfd |
Q9C0B1
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | name | UniProt |
---|---|---|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00409 | Type II diabetes mellitus |
Q9C0B1
(related)
|
H00926 | Growth retardation, developmental delay, coarse facies, and early death |
Q9C0B1
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001943 | Breast Neoplasms |
C00000176
|
D011471 | Prostatic Neoplasms |
C00000176
|
D002471 | Cell Transformation, Neoplastic |
C00001183
|
D019969 | Amphetamine-Related Disorders |
C00001151
|
D018149 | Glucose Intolerance |
C00001151
|
D006461 | Hemolysis |
C00001151
|
D006946 | Hyperinsulinism |
C00001151
|
D006948 | Hyperkinesis |
C00001151
|
D006973 | Hypertension |
C00001151
|
D007333 | Insulin Resistance |
C00001151
|
D009401 | Nephrosis |
C00001151
|
C541083 | Non-alcoholic Fatty Liver Disease |
C00001151
|
D019966 | Substance-Related Disorders |
C00001151
|
D000647 | Amnesia |
C00000091
|